Value
4.4/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 0.0 |
| P/S | 0.0 |
| Fwd P/E | 3.0 |
| PEG | 10.0 |
| Analyst target | 9.0 |
- ▸Forward P/E: 35.3x
- ▸PEG: 0.19
ALAB · Why this verdict
Why Astera Labs (ALAB) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score6.4/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis
Engine thesis — one sentence
Astera Labs is a high-quality, hyper-growth semiconductor business (104% YoY growth, Rule of 40 at 112) trading 48% off its high with 33.1% analyst upside, but 86% of revenue comes from three customers and insiders are selling heavily.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Growth is 104% YoY, with revenue and earnings growth components both at 10.0/10 and a Rule of 40 reading of 112. Growth breakdown | Revenue growth stays above 50% YoY through the next 12 months. | →Stable |
| CounterTriple-digit growth comparisons get harder each quarter, and a forward P/E of 40.4x already prices in sustained growth. | ||
The top three end customers account for 86.0% of revenue, and three high-severity concentration risks are flagged. Bear case | Top three customers fall below 75% of revenue as new customers ramp. | →Stable |
| CounterLosing or delaying orders from one major customer would sharply cut revenue and could be hard to replace. | ||
ROE is 26% and margins are 31%, with gross margin and net margin components both at 10.0/10 and a wide moat. Quality breakdown | Net margin stays above 25% as revenue scales. | →Stable |
| CounterFree cash flow is only 25% of net income, flagged as an earnings quality red flag, so reported profits may not convert to cash. | ||
The $258.70 price is 33.1% below the $344.41 analyst target after a 48% drawdown, with downside to the stop of 15.0% and reward-to-risk of 2.21. Estimated upside | Price recovers toward the analyst target as growth continues. | Tripped→Stable |
| CounterFalling on-balance volume and a 6.7% gap down suggest sellers remain in control and the pullback may extend. | ||
Insiders sold about $127.3M across 102 sales in 90 days with no buying, 0.284% of market cap. Total sell value 90d | Insider net selling slows to under $50M over the next 90 days. | ↑Improving |
| CounterSelling across 102 transactions likely reflects routine pre-scheduled plans and stock compensation, which are small relative to market cap. | ||
Growth is 104% YoY, with revenue and earnings growth components both at 10.0/10 and a Rule of 40 reading of 112.
→StableGrowth breakdown
- Expectation
- Revenue growth stays above 50% YoY through the next 12 months.
CounterTriple-digit growth comparisons get harder each quarter, and a forward P/E of 40.4x already prices in sustained growth.
The top three end customers account for 86.0% of revenue, and three high-severity concentration risks are flagged.
→StableBear case
- Expectation
- Top three customers fall below 75% of revenue as new customers ramp.
CounterLosing or delaying orders from one major customer would sharply cut revenue and could be hard to replace.
ROE is 26% and margins are 31%, with gross margin and net margin components both at 10.0/10 and a wide moat.
→StableQuality breakdown
- Expectation
- Net margin stays above 25% as revenue scales.
CounterFree cash flow is only 25% of net income, flagged as an earnings quality red flag, so reported profits may not convert to cash.
The $258.70 price is 33.1% below the $344.41 analyst target after a 48% drawdown, with downside to the stop of 15.0% and reward-to-risk of 2.21.
Tripped→StableEstimated upside
- Expectation
- Price recovers toward the analyst target as growth continues.
CounterFalling on-balance volume and a 6.7% gap down suggest sellers remain in control and the pullback may extend.
Insiders sold about $127.3M across 102 sales in 90 days with no buying, 0.284% of market cap.
↑ImprovingTotal sell value 90d
- Expectation
- Insider net selling slows to under $50M over the next 90 days.
CounterSelling across 102 transactions likely reflects routine pre-scheduled plans and stock compensation, which are small relative to market cap.
Per-dimension breakdown
Quality
7.9/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 8.6 |
| ROA | 7.1 |
| Gross margin | 10.0 |
| Op margin | 9.1 |
| Net margin | 10.0 |
| Current ratio | 5.0 |
| FCF quality | 2.0 |
| Moat | 9.0 |
| Rule of 40 | 9.5 |
| Piotroski F | 8.9 |
- ▸Excellent ROE: 26%
- ▸Strong margins: 31%
- ▸Earnings quality RED FLAG: 25% FCF/NI
- ▸Wide economic moat
Growth
10.0/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
| EPS growth | 10.0 |
- ▸Strong growth: 104% YoY
Momentum
2.6/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.5 |
| MACD | 0.0 |
| OBV | 1.0 |
| MA position | 2.2 |
| Volume | 6.1 |
- ▸Volume distribution (falling OBV)
- ▸Below 200-MA but MA still rising (+9.7%/30d) — pullback in uptrend, not confirmed weakness
Sentiment
7.5/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 5.5 |
| Analyst rating | 7.5 |
| Price target | 9.8 |
- ▸Analyst upside: 66%
Insider
4.7/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 6.9 |
| notable moves | 7.0 |
- ▸Notable insider selling — $127,306,875 (0.320% of mkt cap)
Peer rank
6.3/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 0.9 |
| quality rank | 7.7 |
| growth rank | 8.3 |
- ▸Industry growth leader
- ▸Conservative debt levels
Technical
5.8/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 8.8 |
| support resistance | 9.5 |
| 52w position | 0.0 |
| gap | 5.0 |
Risk (lower is worse)
4.4/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 7.0 |
| days to cover | 9.0 |
| volatility | 0.0 |
| put call | 6.3 |
| implied vol | 0.0 |
| max pain risk | 3.0 |
| beta | 0.0 |
| debt equity | 9.9 |
- ▸High IV: 129%
- ▸Above max pain $130
- ▸Concentration risks: 3 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
7.6/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| news activity | 8.0 |
- ▸Perfect beat streak: 4Q
- ▸Earnings today
How the verdict was assembled
Engine trigger
Earnings today. Wait until post-earnings.
Engine technical detail
verdict_path:
L4:PATH_C2_GARP_WAIT|EARNINGS:BUY_DEFERRED|ENTRY_STICKY:WITHIN_BANDPassed (5)
- ASYMMETRY:3.3>=1.5
- INSIDER:OK
- 8K:CLEAN
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- MOMENTUM:2.6<4.5
- EARNINGS_PROXIMITY:0d<=7d
Warning (0)
none
Reward-to-Risk
3.29
Upside
+49.3%
Downside
15.0%
Sizing output
STARTER
Setup— — No clear chart pattern; technical signals are mixed
EdgeTemporary headwind — High quality (7.9) with weak momentum (2.6)
SuitabilitySpeculative — Drawdown -53% (>40% off 52w high)
Investment implication
The C-path quality+growth combination triggered the STRONG_BUY_WAIT verdict: quality 7.9 and growth 10.0 both clear their thresholds, with asymmetric R:R of 3.29 supporting the read.
The strongest dimensions are Growth at 10.0, Quality at 7.9, and Catalyst at 7.6; the weakest are Momentum at 2.6, Risk (lower is worse) at 4.4, and Value at 4.4. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of 3.29 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Hypergrowth Profile
Trip ifRevenue growth falls below 40% YoY for 2 consecutive quarters.
- P2High Quality Margins
Trip ifNet margin falls below 20% from current 31%.
- P3Customer Concentration Risk
Trip ifTop three customer share of revenue exceeds 90% from current 86.0%.
- P4Analyst Upside After DrawdownTripped
Trip ifShare price falls below the $241.62 stop level, a drop of more than 6.6%.
- P5Heavy Insider Selling
Trip ifInsider selling exceeds $250M over 90 days.